A human c-sis cDNA in an expression vector was introduced into human diploid fibroblasts by transfection or electroporation. Fibroblast clones showing an aberrant, densely packed colony morphology were isolated and found to overexpress a 3.6-kilobase sis mRNA species and associated immunoprecipitable platelet-derived growth factor (PDGF) 2 proteins. Parallel analyses in cell clones of sis mRNA expression and colony formation in agar indicated that, above a threshold, a linear, positive correlation existed between sis overexpression and acquired anchorage independence. The sis-overexpressing cells formed transient, regressing tumor nodules when injected into nude mice, consistent with the finite life span which they retained. Protein products generated from the transfected c-sis construct in two overexpressing clones were immunoprecipitated with anti-human PDGF antibodies. One clone contained an apparent PDGF dimer of 21 kilodaltons; the second clone contained only an apparent PDGF monomer of 12 kilodaltons, which was shown to account for all of the mitogenic activity present in the cells, essentially all of which was concentrated in the membrane fraction. The results demonstrate a clear link between sis overexpression and acquisition of a partially transformed, anchorage-independent phenotype, and when combined with previous observations of sis overexpression in human tumors, clearly implicate sis overexpression as a genetic mechanism which contributes to human cell transformation.
A human c-sis cDNA in an expression vector was introduced into human diploid fibroblasts by transfection or electroporation. Fibroblast clones showing an aberrant, densely packed colony morphology were isolated and found to overexpress a 3.6-kilobase sis mRNA species and associated immunoprecipitable platelet-derived growth factor (PDGF) 2 proteins. Parallel analyses in cell clones of sis mRNA expression and colony formation in agar indicated that, above a threshold, a linear, positive correlation existed between sis overexpression and acquired anchorage independence. The sis-overexpressing cells formed transient, regressing tumor nodules when injected into nude mice, consistent with the finite life span which they retained. Protein products generated from the transfected c-sis construct in two overexpressing clones were immunoprecipitated with anti-human PDGF antibodies. One clone contained an apparent PDGF dimer of 21 kilodaltons; the second clone contained only an apparent PDGF monomer of 12 kilodaltons, which was shown to account for all of the mitogenic activity present in the cells, essentially all of which was concentrated in the membrane fraction. The results demonstrate a clear link between sis overexpression and acquisition of a partially transformed, anchorage-independent phenotype, and when combined with previous observations of sis overexpression in human tumors, clearly implicate sis overexpression as a genetic mechanism which contributes to human cell transformation.
The transforming sequence of simian sarcoma virus (SSV), v-sis, has been shown to code for the protein p28sis which, after cellular processing, yields a dimer nearly identical in primary sequence and structure to the human platelet-derived growth factor (PDGF) 2 dimer (7, 30, 35) . Elevated levels of c-sis mRNA, derived from the human cell homolog of v-sis, have been detected in several human tumors of mesenchymal origin, including fibrosarcomas, osteosarcomas, and glioblastomas (8) , cells whose nontransformed counterparts produce no detectable sis-specific mRNA. PDGF-like proteins have also been measured in culture medium and in lysates of SSV-transformed fibroblasts (4, 6, 10, 15, 25) , as well as in some human tumor cell lines (2, 24) , and anti-PDGF antibodies have been shown to inhibit the morphological and mitogenic effects which pure PDGF or lysates from SSV-infected cells have upon normal mammalian fibroblasts.
In the large majority of human tumors of mesenchymal origin, a common phenotype is the ability of the tumor cells to grow in an anchorage-independent fashion when suspended in soft agar (26, 27) . To determine whether acquisition of this common tumor phenotype was related to overproduction of PDGF resulting from overexpression of the c-sis gene, we introduced multiple copies of an expression vector containing a human c-sis cDNA clone into human diploid fibroblasts, using either transfection or electroporation. We report here that acquisition of anchorage-independent growth shows a linear, positive correlation with the level of expression of the c-sis coding sequence in human fibroblasts. We also describe one c-sis-overexpressing hu-* Corresponding author. man fibroblast clone which produces high levels of a 12-kilodalton (kDa) PDGF species, a probable PDGF-2 monomer which retains full mitogenic activity and the associated ability to induce anchorage independence in the host human fibroblasts.
MATERIALS AND METHODS Cells and plasmids. Two populations of normal human fibroblasts were used in these experiments. One (25sk) was initiated from foreskin material by cell outgrowth from tissue pieces submerged in Dulbecco modified Eagle medium (DME) plus 20% fetal bovine serum beneath cover slips; the other was from a collagenase-dispersed human foreskin sample. HT1080, a human fibrosarcoma cell line, and A172, a human glioblastoma cell line, were obtained from the American Type Culture Collection, Rockville, Md. The pSM-1 plasmid contains a c-sis cDNA prepared from the mRNA of the human HUT-102 tumor cell line and is under control of the early region promoter and the late mRNA polyadenylation signal of simian virus 40 (5).
Transfection protocol. Human fibroblasts were treated between passages 2 and 4 by a previously described transfection protocol (33) . Briefly, 0.2 x 106 cells were seeded into 60-mm-diameter dishes. Eighteen hours later, cells were rinsed twice with phosphate-buffered saline (PBS); after a 2-min shock with polyethylene glycol (45 g of polyethylene glycol 8000 plus 90 ml of DME), 0.50 ml of the calcium phosphate-DNA (0 to 40 ,ug of nonlinearized plasmid, calf bovine serum. On the second day after transfection, each 60-mm-diameter dish was split into two 100-mm-diameter dishes, and 1 day later, G418 (400 ,ug/ml, certified G418 content) was added in DME plus 20% fetal bovine serum; at 4-day intervals, dishes were refed with DME with 20% fetal bovine serum containing 100 ,ug of G418 per ml. Dishes were stained 21 days posttransfection with crystal violet.
Electroporation protocol. Human fibroblasts (106, same cells as above), suspended in 0.5 ml of PBS (4°C) containing 0 to 50 ,ug of pSV2neo (nonlinearized), received a single pulse from an electroporation apparatus (University of Wisconsin Medical Electronics). This four-capacitor unit was charged to 1,500 V and delivered transient currents of 4.0 to 4.5 A through a 1-cm gap between aluminum electrodes with a decay time constant of 20 to 25 ms. Cells were then diluted into DME plus 20% fetal bovine serum and plated into a 150-mm-diameter dish. Three days later, G418 (400 ,ug/ml) was added in DME plus 20% fetal bovine serum. The remaining feeding, staining, and scoring were performed as described above. The cell kill induced by electroporation at various voltages was determined by the cloning efficiency of cells (200 cells per 60-mm-diameter dish) removed from the cuvette after a single pulse. The voltage yielding the optimum number of drug-resistant colonies per treated cell (i.e., 1,500 volts) was used for the DNA concentration curve described above.
Northern (RNA) blot analysis. Cytoplasmic RNA was isolated (22) , and aliquots (25 ,ug) were fractionated by electrophoresis in 1.2% agarose gels containing 2.2 M formaldehyde. RNAs from six 25sk and 7-29 G418-resistant clones which were never exposed to pSM-1 were separately pooled before electrophoresis to serve as a negative control for sis hybridization analyses. RNA was transferred onto nitrocellulose by blotting with lOx SSC (lx SSC is 0.15 M NaCI plus 0.015 M sodium citrate), and hybridization was done at 42°C in 50% formamide. Filters were washed in 0.1 x SSC at 65°C and autoradiographed. The probe used was a nick-translated 2.3-kilobase (kb) BamHI fragment from the sis coding region of pSM-1 (17) . The sizes of the 28S and 18S rRNA species were used to assess the size of the sis transcript.
Soft agar cloning. Soft agar growth was determined by the previously described procedure (23) . Briefly, 105 cells were seeded per 60-mm-diameter dish into 0.33% Noble agar (Difco Laboratories) in Ham F10 medium supplemented with 6% fetal bovine serum (Hyclone). To determine plating efficiency on plastic, an aliquot of cells in molten agar was diluted to 200 cells per 5 ml of Ham F10 plus 6% fetal bovine serum. Agar dishes were fed with 1 ml of Ham F10 plus 6% fetal bovine serum on day 1 and day 14 after seeding. Four weeks after seeding, all agar colonies of >75 pum in diameter were counted and the colony counts were normalized to the plating efficiencies which aliquots of the initially seeded cells showed on plastic. Control cells (from a pool of colonies with pSV2neo alone) gave an average background of 4 colonies per 105 cells seeded into agar; this same cell population gave 20% plating efficiency in plastic dishes. This gives a background of 4/(20/100) = 20 colonies per 105 normalized cells. Colony counts for each clone were normalized to 105 cells in the same fashion with the plastic plating efficiency of each clone, and the background frequency of 20 colonies per 105 normalized cells was then subtracted from the frequency observed for each clone to yield the plotted value.
Immunoprecipitation. A modification of the procedure described by Robbins et al. (31) was used. Subconfluent cultures in 10-cm-diameter petri dishes were labeled for 4 h at 37°C with 4 ml of cysteine-free Earle minimal essential medium containing 200 ,uCi of [35S]cysteine. To generate conditioned medium, the medium containing labeled cysteine was removed and replaced with 4 ml of cysteine-free Earle minimal essential medium, incubated for 30 min, aspirated, and concentrated to a volume of 0.5 ml. Cellular membrane fractions were prepared by suspending the labeled cells in PBS (pH 7.2)-i mM phenylmethylsulfonyl fluoride, lysing the cells by sonication (once for 8 s), centrifuging the sonicate at 800 x g to obtain the postnuclear supernatant, and then centrifuging the postnuclear supernatant at 100,000 x g to separate the soluble proteins (S-100) from the pelletable cellular membrane fraction (P-100). The S-100 fraction (500 pu) was removed and diluted with 500 p.1 of 2x buffer A, which was composed of 10 mM NaH2PO4, 200 mM NaCl, 2% Triton X-100, 1% sodium deoxycholate, 0.2% sodium dodecyl sulfate (SDS), and 0.04% sodium azide (pH 7.5). The P-100 fraction was gently washed with 200 p.l of PBS (pH 7.2) and then suspended with 1 ml of lx buffer A. The P-100 fraction, the S-100 fraction, and the concentrated, conditioned medium were incubated with 3 p. A. Immunoprecipitates were suspended in sample buffer which contained 30% glycerol, 0.04% SDS, and 0.1% M Tris hydrochloride (pH 6.8) and boiled for 3 min (nonreducing conditions). All samples were analyzed by using 14% SDSpolyacrylamide gel electrophoresis (18) .
Mitogenic assay. The mitogenic activity recoverable from c-sis-overexpressing human fibroblasts was determined by the procedure of Leal et al. (19) . Briefly, exponentially growing cell cultures were suspended in 1 mM potassium phosphate (pH 6.8) and lysed by sonication. The postnuclear supernatant of the lysed cells was centrifuged for 90 min at 100,000 x g to pellet the cellular membrane fraction. The membrane fraction was suspended in 10 mM sodium phosphate (pH 7.2), heated for 5 min at 100°C, and clarified by centrifugation at 100,000 x g for 45 min. Protein concentration in the clarified supernatants was determined by the method of Lowry et al. (21) . NIH 3T3 cells were seeded into 96-well plates and grown in DME containing 10% fetal bovine serum to near confluence. The medium was then changed to DME containing 0.2% bovine serum albumin and further incubated for 2 days. Aliquots of the mitogencontaining membrane extracts were added to individual wells, and 12 h later, the medium was supplemented with 2 ,uCi of [3H]thymidine (18 Ci/mmol) per well and incubated for an additional 12 h. The labeled medium was removed, and 0.2 N NaOH (100 p.1 per well) was added to solubilize the cells. Radioactivity in cell material precipitated in 10% trichloroacetic acid was measured by scintillation counting. Human PDGF was obtained from Collaborative Research, Inc.
HPLC size fractionation of mitogenic activity from a c-sisoverexpressing human fibroblast clone. A clarified membrane extract (see above) was prepared from 8 x 106 cells of clone 3-3-2; half of this extract (175 p.l) was fractionated by chromatographing through two Du Pont GF250 columns (in series) which were eluted isocratically with 0.2 M sodium phosphate (pH 7.5) at 0.5 ml/min. Fractions (0.2 min) were collected from 35 to 50 min postinjection. Comparison to the retention times for proteins of known molecular weight was used to determine the molecular weight of the mitogen species observed in the clone 3-3-2 extract. To reduce the phosphate concentration, high-pressure liquid chromatography (HPLC) column fractions (100 ,ul) were individually diluted to a volume of 2 ml with water and individually centrifuged in Centricon 10 microconcentrators (10,000-kDa cutoff), and the residual volume (50 ,ul) was then divided between replicate wells of a 96-well plate to measure mitogenic stimulation.
RESULTS
Electroporation and transfection of human fibroblasts. To determine whether overexpression of the human c-sis gene, now devoid of the additional 5' gag or env sequences present in the feline sarcoma virus or SSV v-sis genes, would induce an anchorage-independent phenotype in human diploid fibroblasts, we transfected an expression vector containing a human c-sis cDNA (pSM-1), together with a selectable genetic marker (pSV2neo), into human diploid fibroblasts. The frequency of introduction of the selectable marker pSV2neo alone into human fibroblasts was first optimized by using either polyethylene glycol-calcium phosphate transfection (33) or electroporation (29, 32 Aberrant morphology in clones expressing sis mRNA. Using the optimized transfection protocol, we cotransfected pSM-1, along with pSV2neo, into two independently isolated foreskin populations of human fibroblasts (25sk and and carried the cells in selective medium for 28 days. The majority of the colonies in the pSM-1 plus pSV2neo dishes were large in diameter and showed starlike morphology ( Fig.  2A and B) with dense cords of slender spindle-shaped cells radiating from the colony center. Small colonies from pSM-1 plus pSV2neo dishes showed the same size and morphology as colonies seen in dishes which received pSV2neo alone (Fig. 2C) . Dishes which received pSM-1 alone and which were propagated without selective medium for 28 days contained several foci (Fig. 2D) which had overgrown the fibroblast monolayer and which showed the same general morphology as that seen in large colonies ( Fig. 2A and B) . Both large and small G418-resistant colonies from dishes of pSM-1 plus pSV2neo or of pSV2neo alone were isolated with cloning cylinders and expanded in selective medium. RNA was isolated from each clonal population and characterized by Northern blot analysis using a 32P-labeled 2.3-kb BamHI fragment from the sis coding region of pSM-1 as a hybridization probe. A single 3.6-kb mRNA species was detected at various levels in >70% of the colonies taken from the pSM-1 plus pSV2neo dishes of both cell populations (Fig. 3) . This size transcript would be predicted from the known sequence of the c-sis cDNA in pSM-1 (17) . Consistent with earlier observations (8) , no sis transcripts were detected in either of the pooled normal human fibroblast controls.
sis-overexpressing cells formed large colonies on plastic with dense, radiating cords of cells (Fig. 2) . When cells from a pool of control clones and a sis-overexpressing clone (2-6a)
were seeded into 24-well plates, the saturation density of 2-6a was four-to sixfold higher than that of the control human fibroblasts and approached the saturation density reported for SSV-infected human fibroblast clones (9) . The increased saturation density was achieved by compression of the cells (Fig. 4A ) into a normal aligned architecture similar to that shown by control human fibroblasts (Fig. 4B) or by the overlapping of these organized sheets of cells. Northern blot analysis of c-sis RNA levels in clonal populations of human fibroblasts after pSM-1 pSV2neo transfection and G418 selection. Cell clones (control) from dishes containing pSV2neo alone or cell clones (4b-2 through 4c-2 from 25sk cells and 2-3c through 2-2a from 7-29 cells) from dishes with pSV2neo plus pSM-1 were isolated with cloning cylinders and individually expanded to 50 x 106 cells in G418 medium (100 Rg/ml). Cytoplasmic RNA was isolated, and aliquots (25 ,ug) were fractionated by electrophoresis in 1.2% agarose gels containing 2.2 M formaldehyde. The probe used a nick-translated 2.3-kb BamHI fragment from the sis region of pSM-1 (17) . The sizes (in kilobases) of the 28S and 18S ribosomal RNA species are indicated to the right of each gel and have been used to assess the size of the sis transcript. 20 ,ug of pSV2neo (C), or 20 ,ug of pSM-1 (D). (A through C) G418-resistant colonies were either isolated with cloning cylinders or stained and photographed after 28 days of growth (400 1Lg of G418 per ml in DME plus 20% fetal bovine serum on day 3 posttransfection, 100 Rg of G418 per ml on day 7, and then no further feeding).
(D) sis-induced foci were photographed after 28 days in dishes which had received DME plus 10% fetal bovine serum twice after transfection.
Although the overexpressing cells grew to a much higher density, they did so in an organized fashion; they did not assume the random, crisscross morphology of many neoplastic cells. Consistent with this, none of the sis-overexpressing cells (clones 2-5a, 2-2a, and 2-6a; 2 x 106 cells per injection site; four injection sites per clone) induced tumors in nude mice through 6 months of observation. The sisoverexpressing clones did form small, transient cell nodules at the injection site which were visible for up to 2 weeks; these were not present at injection sites for control 7-29 cells.
sis-induced anchorage independence. Each of the expanded large colonies, as well as a pool of small colonies from dishes with pSV2neo alone, were seeded into soft agar and were also plated onto plastic as described in Materials and Methods. After 28 days, agar colonies greater than 75 ,um in diameter were counted, and the agar colony counts were normalized for the plating efficiency which each cell group originally showed when plated on plastic. Figure 5 shows for two cell populations plots of the frequency of anchorageindependent colony formation versus sis-specific mRNA levels measured in a portion of the clonal cell populations originally seeded into agar. A clear positive correlation between increasing agar colony frequency and increasing sis-specific transcript was observed. In both cell populations (Fig. 5) , it was clear that a threshold of sis expression had to be exceeded before enhanced anchorage-independent growth was induced. In Fig. Sb, the 23) . At 4 weeks postseeding, all agar colonies of >75 ,um in diameter were counted and the colony counts were normalized for the plastic plating efficiencies. sis-specific mRNA levels were determined by densitometric tracing of the 3.6-kb band present in Northern blots (see Fig. 3 ). Because experiments 1 and 2 were done at different times, the densitometric sis units between experiments are not necessarily the same. Anch. Ind. Cols., Anchorage-independent colonies. 3-32, 3-3-2; 3-63, 3-6-3. tumorigenic, anchorage-independent human fibrosarcoma cell line, HT1080, was used; it produced 2,264 colonies per 105 normalized cells. Although we have not yet determined sis-specific mRNA levels for this cell line, previously published reports have shown both the presence of a codon 61 N-ras mutation (13) , as well as overproduction of transforming growth factor P in these cells. Interestingly, treatment of mouse cells with transforming growth factor a has been shown to markedly induce c-sis mRNA production (20) .
Structural, functional characteristics of PDGF generated in sis-overexpressing human fibroblast clones. Two clones of cells, overexpressing sis at a high (3-3-2) or low 3-6-3) level (3- 32 Immunoprecipitation of PDGF species from cell fractions or medium derived from normal or sis-overexpressing human fibroblast clones or A172 human glioblastoma cells. Cells were labeled for 4 h with [35S]cysteine, and conditioned medium or subcellular fractions (P-100 and S-100, pellet and supernatant from 100,000 x g spin of a postnuclear supernatant, respectively) were prepared as described in Materials and Methods. Concentrated medium or cell fractions derived from 2 x 106 of each cell type were subjected to immunoprecipitation with goat anti-human PDGF.
Immunoprecipitates were dissolved and boiled in SDS-polyacrylamide gel electrophoresis sample buffer in the absence of reducing agent and electrophoresed in a 14% acrylamide gel. Mobilities of molecular weight standards (left) and bands of interest (right) are indicated (in kilodaltons).
c-sis gene. The polyclonal PDGF antisera used here were generated either in rabbit (obtained from Thomas Deuel) or goat (purchased from Collaborative Research); both preparations immunoprecipitated the same protein species as those shown in Fig. 6 . Under nonreducing conditions in clone 3-3-2 (Fig. 6 ), a prominent band was visible at 12 kDa which was not seen in the control cell population, and this band did not dissociate when electrophoresed under reducing conditions (data not shown). In clone 3-6-3, a much less intense band was observed at 21 kDa. On the basis of densitometric analysis of the 12-kDa band found in 3-3-2 (lanes 1 through 3), greater than 90% of the PDGF-2 generated in these cells was concentrated within the cell membrane fraction. This supports the previous observations of Igarashi et al. (16) using c-sis-expressing cells. The A172 glioblastoma cells also contained immunoprecipitable PDGF in their membrane fraction at a level (integrated sum of 16.2-and 19.4-kDa bands) equivalent to the overexpressing clone 3-3-2.
When PDGF-containing membrane extracts from clones 3-3-2 and 3-6-3 were tested for mitogenic activity, the level of stimulation of serum-deprived NIH 3T3 cells (Table 1) closely correlated with the level of PDGF species observed with immunoprecipitation (Fig. 6) . A 25-fold increase in mitogenesis for clone 3-3-2 was reflective of 18.7 densitometric units for integration of the 12-kDa band in the 3-3-2 immunoprecipitate. Likewise, a twofold mitogenic increase for clone 3-6-3 was associated with 1.7 densitometric units for the 21-kDa band in the 3-6-3 immunoprecipitate (Fig. 6 ). A comparison of the high-and low-sis-expressing clones 3-3-2 and 3-6-3 indicates that in these clones there is a predictable and consistent relationship between the levels of c-sis mRNA, immunoprecipitable PDGF, and extractable mitogen, as well as the phenotypes induced by sis overexpression, namely, increased saturation density and anchorage-independent growth. This relationship is summarized in Table 2 .
Mitogenic activity of 12-kDa PDGF species. On the basis of the densitometric area of the 12-kDa band in the clone 3-3-2 P-100 lane (Fig. 6) , this peptide seemed to be the most likely candidate to explain the high level of mitogenic activity which we had shown to reside in this membrane fraction (Table 1) . To further probe this somewhat surprising observation, an aliquot of 3-3-2 membrane extract was chromotographed by HPLC on a molecular sieve column (Fig. 7) . Under conditions where the 12-kDa protein was chromatographically well separated from other immunoprecipitable proteins in the 3-3-2 extract (in particular, the 30-kDa band), all of the detectable mitogenic activity was found to migrate with a molecular mass of 12 kDa.
DISCUSSION
In these experiments, our goal was to overexpress a human c-sis cDNA in normal human fibroblasts and determine whether this single event would induce any of the tumor-associated phenotypes which are commonly observed in human mesenchymal tumors. Our results indicate the following. (i) Overproduction of sis mRNA and its associated PDGF-2 translational product is associated with a substantial increase in the ability of these fibroblasts to grow in agar, a phenotype which is commonly associated with the majority of human mesenchymal tumors. (ii) The induced anchorage independence occurred at levels of PDGF-2 overproduction which were similar to the level of PDGF measured in a naturally occurring human mesenchymal tumor. (iii) A 12-kDa immunoprecipitable PDGF species from one sis-overexpressing clone, which probably presents a monomeric PDGF-2 peptide, was strongly mitogenic.
Overexpression of c-sis (PDGF-2), as well as generation of mitogenic peptides which are immunoprecipitable with anti-PDGF antibodies, has now been described as occurring in human tumors of both mesenchymal (2, 3, 8, 16 ) and epithelial (16, 28) (Fig. 6 and 7) (14) . Because this 12-kDa band did not dissociate when the electrophoresis sample was prepared under reducing conditions (5% ,-mercaptoethanol, 100°C for 3 min), we conclude that the protein is a monomer. One reason why the 12-kDa protein fails to dimerize might be that a mutation has occurred during transfection of the c-sis cDNA at a codon encoding one of the eight cysteine residues in the core PDGF-B molecule previously reported (12, 14) to be necessary for dimerization to occur. From the results of Giese et al. (12) , such a mutation would need to occur at one of only four cysteine residues (residues 127, 160, 171, and 208) for the resulting monomer to retain HPLC size fractionation of mitogenic activity from c-sis overexpressing fibroblast clone 3-3-2. A membrane extract from clone 3-3-2 cells or, in a separate injection, proteins of known molecular weight (inset; 1, apoferritin; 2, alcohol dehydrogenase; 3, ovalbumin; 4, carbonic anhydrase; 5, a-lactalbumin; 6, acetone) were separated on a molecular sieve column (two Du Pont GF250 columns in series) as described in Materials and Methods. Column fractions were assayed for mitogenic activity (as in footnote a to Table 1 ). The gel lane (from The results of this study indicate that overexpression of the human c-sis gene can induce anchorage-independent growth, which is a common tumor-associated phenotype among the majority of human and rodent tumors of mesenchymal origin (26, 27) . Acquisition of anchorage independence in rodent cells, when complemented by one or more additional genetic events, such as extended culture life span or immortality, is highly correlated with the ability to form progressively growing tumors (1) . The ability of the c-sis coding sequence to induce tumorigenic NIH 3T3 foci (1, 11) is consistent with this scenario. In contrast, however, acquisition of anchorage independence in human diploid fibroblasts, when induced either by mutagen treatment (23, 34 ; C. W. Stevens, T. H. Manoharan, and W. E. Fahl, Proc. Natl. Acad. Sci. USA, in press) or by oncogene transfection, appears to be limited principally to the acquired ability of these cells to grow in agar, and whatever the in vivo correlate of this phenotype represents. This observation suggests that c-sis overexpression alone serves to induce partial transformants and supports the hypothesis that multiple, activated oncogenes are needed to neoplastically transform human cells. Because of this, studies in which sisinduced anchorage independence is complemented by additional oncogenes with known associated phenotypes (e.g., induced extended culture life span) should be useful. However, the results from this present study already indicate that the recurrent observations of sis overexpression and anchorage-independent growth in human mesenchymal tumor cells (8, 26, 27) are mechanistically related. Additional activated genes in the mesenchymal tumors could certainly contribute to the ability of the tumor cell to grow in agar, but the results of the experiments presented here indicate that the c-sis overexpression commonly found in human mesenchymal tumors is sufficient to explain acquired anchorageindependent growth.
